Fatty Liver News and Research

Latest Fatty Liver News and Research

Better methods needed to identify people at risk for liver disease

While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

27 Sep 2019

Research: Protein complex represents a new metabolic target for liver cancer

Disrupting a metabolic pathway in the liver in a way that creates a more "cancer-like" metabolism actually reduces tumor formation in a mouse model of liver cancer.

24 Sep 2019

Blue-green algae pose threat to patients with liver disease

Researchers are calling for new guidelines for people with pre-existing liver disease who are exposed to a toxin released by blue-green algae.

19 Sep 2019

New protein could offer a fresh target for cancer treatment

A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.

19 Sep 2019

Toxic algae may be more harmful for people with pre-existing liver disease

Toxins produced during harmful algal blooms may be more harmful to people than previously known.

19 Sep 2019

UT Southwestern researchers identify novel mechanism that regulates fat formation

In work suggesting new therapeutic targets to fight obesity, UT Southwestern researchers have identified a novel mechanism that regulates the creation of fat in mammals.

18 Sep 2019

Obesity stigma and yo-yo dieting, not BMI, are behind chronic health conditions, dietitian claims

In a recent New York Times opinion column, dietitian Christy Harrison, an "intuitive eating coach" and author, responded to a fellow clinician who had questioned some of her thoughts on the link between being overweight and developing other medical conditions.

17 Sep 2019

Researchers discover link between alcohol-producing gut bacteria and NAFLD

Non-alcoholic fatty liver disease is the build-up of fat in the liver due to factors other than alcohol. It affects about a quarter of the adult population globally, but its cause remains unknown.

17 Sep 2019

New insight into origin of diabetes in overweight patients

In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing. Obesity, by promoting the resistance to the action of insulin - one of the hormones that regulate blood sugar levels - is a major risk factor.

12 Sep 2019

Taller people at lower risk for type 2 diabetes

A new German study has found that taller people are at a lower risk of developing type 2 diabetes. The study titled, “Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors,” was published in the latest issue of the journal Diabetologia.

11 Sep 2019

Insulin imbalance may not be the only cause of diabetes

In Switzerland, more than 400,000 people suffer from type 2 diabetes, a serious metabolic disorder that is constantly increasing.

11 Sep 2019

'Lab on a chip' technology may help find new treatments for NAFLD

Non-alcoholic fatty liver disease--the accumulation of liver fat in people who drink little or no alcohol--is increasingly common around the world, and in the United States, it affects between 30 and 40 percent of adults.

29 Aug 2019

Researchers discover how fatty liver disease develops in lean people

Researchers from The Westmead Institute for Medical Research (WIMR) have discovered how fatty liver disease develops in lean people, aiding the development of potential treatments for these patients.

26 Aug 2019

Enzyme induced by stress associated with liver cancer growth

An enzyme induced by stress to help reduce production of damaging free radicals is also used by liver cancer to regulate two major cell proliferation pathways that enable the cancer to thrive, scientists report.

22 Aug 2019

Study explores if fecal transplants can improve outcomes in melanoma patients

A multidisciplinary team at Lawson Health Research Institute is exploring whether fecal transplants can improve outcomes in melanoma patients treated with immunotherapy.

19 Aug 2019

HistoIndex, ILBS launch Center of Excellence to enhance NASH diagnostics and clinical trials

In a cross border collaboration, HistoIndex and the Institute of Liver & Biliary Sciences (ILBS) in New Delhi, India have jointly launched a Centre of Excellence to aid diagnostics and clinical trials focusing on NASH.

8 Aug 2019

Pitt researchers first to grow genetically modified miniature human livers in the lab

Researchers at the University of Pittsburgh School of Medicine are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

7 Aug 2019

Trial shows nor-urso as an effective treatment option for nonalcoholic fatty liver disease

A team led by Michael Trauner at MedUni Vienna's Division of Gastroenterology and Hepatology demonstrated the beneficial effect of synthetically produced bile acid with the active agent nor-ursodeoxycholic acid (nor-urso) in the hitherto incurable liver disease primary sclerosing cholangitis (PSC) around two years ago.

29 Jul 2019

MGH study shows the importance of fatty acid balance in chronic disease

Using novel transgenic mouse models they developed, Massachusetts General Hospital investigators have provided new evidence that it is the ratio of omega-6 and omega-3 fatty acids, rather than the total amount of them, that influences risk of developing chronic disease.

27 Jul 2019

Non-exercisers more likely to have fatty liver disease

"Training with high enough intensity to improve fitness can be important both for preventing and treating fatty liver disease," says Ilaria Croci, a postdoctoral fellow in Norwegian University of Science and Technology's Cardiac Exercise Research Group and at the University of Queensland in Australia.

26 Jul 2019